USANA HEALTH SCIENCES INC
For the period ended Apr 22, 2025. Filed Apr 22, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Apr 22, 2025 · Filed Apr 22, 2025
USNA$13.63-1.7%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (in thousands, except per share data)
(in thousands, except per share data)
| Quarter Ended | ||
|---|---|---|
| March 29,2025 | March 30,2024 | |
| Net sales | $249,539 | $227,800 |
| Cost of sales | 52,445 | 43,069 |
| Gross profit | 197,094 | 184,731 |
| Operating expenses: | ||
| Associate incentives | 89,985 | 95,758 |
| Selling, general and administrative | 91,438 | 64,300 |
| Total operating expenses | 181,423 | 160,058 |
| Earnings from operations | 15,671 | 24,673 |
| Other income (expense): | ||
| Interest income | 723 | 2,676 |
| Interest expense | (411) | (52) |
| Other, net | 756 | (186) |
| Other income (expense), net | 1,068 | 2,438 |
| Earnings before income taxes | 16,739 | 27,111 |
| Income taxes | 7,449 | 10,574 |
| Net earnings | 9,290 | 16,537 |
| Less: Net earnings (loss) attributable to redeemable noncontrolling interest | (112) | — |
| Net earnings attributable to USANA | $9,402 | $16,537 |
| Earnings per common share attributable to USANA | ||
| Basic | $0.49 | $0.86 |
| Diluted | $0.49 | $0.86 |
| Weighted average common shares outstanding | ||
| Basic | 19,049 | 19,174 |
| Diluted | 19,085 | 19,302 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.